- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
- News News
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit
- Join Join
Policy Recommendations Ohio
2019-2020 Improvements and Recommendations for Ohio
Ohio continues efforts to organize a functional medical cannabis system since first opening licensed medical cannabis businesses to serve patients in 2019. Of the 57 dispensaries licenced to serve the state, 51 are now open.44 Of the 32 authorized cultivators, twenty are operational. Meanwhile only 14 of 43 authorized medical cannabis processors have been licensed. 2019 also saw state regulators review petitions to include 27 new conditions eligible for participation in the state's medical 45access program, and reject all but one for Cachexia/Wasting Syndrome.
ASA applauds the state's efforts to deem medical cannabis businesses essential during the COVID pandemic, and organize other access features to assist patients such as permitting curbside pickup and allowing patients to reenroll in the state's program via telehealth appointments. Beyond these improvements Ohio regulators should also consider authorizing delivery from medical cannabis storefronts to patients to ease patient travel burdens and reduce the risk of patient social engagement in retail settings.
As Buckeye State lawmakers return for the 2021 legislative session, ASA also recommends expanding the list of qualifying conditions to include chronic pain and anxiety, as well as authorizing patients to cultivate medical cannabis at home. These recommendations will ensure that a larger population of eligible patients who would benefit from a safe access program organized by the state can participate, and provide ambulatory patients with a more cost-effective treatment option.